Brought to you by 
Teva and Takeda enter into new venture for generics in Japan
31 Jul 2020
Executive Summary
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Co. Ltd. entered into a new partnership in Japan. The new venture will begin in Q2 2016 with Teva owning 51% and Takeda 49%. The partnership will operate as an independent company with its own board and management team. Further details have not yet been disclosed.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Teva and Takeda enter into new venture for generics in Japan
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice